Navigation Links
EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown
Date:6/28/2011

the next clinical evaluation of ENMD-2076."

In connection with the execution of the SEDA, EntreMed paid Yorkville a one-time fee of $26,000 and issued YA Global 39,741 shares of common stock as a commitment fee.  The SEDA permits EntreMed to terminate the agreement at any time, subject to the advance notice provision, and to pursue any other financing alternatives available to the Company.  The Company intends to use the net proceeds from the initial advance, which are expected to be approximately $1.0 million after deducting the offering expenses, including fees paid to Yorkville and to Ferghana Securities, Inc., the Company's financial advisor, for working capital.

These securities are being offered through a prospectus supplement and accompanying base prospectus pursuant to the Company's effective shelf registration statement, previously filed and declared effective by the Securities and Exchange Commission (the "SEC").  The prospectus supplement related to the offering will be filed with the SEC.  Copies of the final prospectus supplement and accompanying base prospectus can be obtained at the SEC's website at www.sec.gov.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state.

About ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed ENMD-2076 Phase 2 Data to Be Presented at ASCO Annual Meeting
2. EntreMed Reports First Quarter 2011 Financial Results
3. EntreMed Reports Third Quarter 2010 Financial Results
4. EntreMed Receives Notice of NASDAQ Compliance
5. EntreMed Secures $5.1 Million in Registered Direct Offering and Enters into Agreement for Rights to License ENMD-2076 in China
6. EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
7. EntreMed Reports Second Quarter 2010 Financial Results
8. EntreMeds ENMD-2076 Active in Solid and Hematological Cancers
9. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
10. EntreMed Presents Initial Clinical Results for ENMD-2076
11. EntreMed Receives New Patent for 2-Methoxyestradiol Analogs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014  Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), ... the development of brachytherapy devices and medical isotopes ... it has filed a de novo ... for marketing clearance for its patented Y-90 RadioGel(TM) ... Food, Drug and Cosmetic Act (the "Act").  ...
(Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
(Date:12/24/2014)... , Dec. 23, 2014  The American Diabetes ... pressure target for people with diabetes and that ... high doses of statins, in keeping with recent ... by the American College of Cardiology (ACC) and ... in the most recent changes to the Association,s ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4
... , May 13 Pacific Bridge Medical, a leading Asia ... on May 26, 2010 at 11am EDT . , ... Taiwan is the sixth largest pharmaceutical market in the ... a solid national health care system. This webcast will give an overview of ...
... , SEATTLE , May 13 ... company, today announced that, based on successful preclinical studies, ... MASP-2 antibody program and has initiated the cGMP manufacturing ... have shown that Omeros, proprietary, fully human, monoclonal MASP-2 ...
Cached Medicine Technology:Pacific Bridge Medical to Host Taiwan Drug Registration Webinar 2Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 2Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 3Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders 4
(Date:12/24/2014)... 24, 2014 (HealthDay News) -- Adults who experienced ... of migraine headaches, suggests a study published online ... "Childhood maltreatment can have long-lasting effects, like ... adulthood," study author Dawn Buse, director of behavioral ... City, said in a journal news release. ...
(Date:12/24/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... start smoking or drinking with each additional symptom they ... new research suggests. "Our findings underscore the ... use as [these] children approach adolescence," said study author ... Group, which is part of Cincinnati Children,s Hospital. "This ...
(Date:12/24/2014)... Reinberg HealthDay Reporter TUESDAY, ... American Diabetes Association (ADA) call for giving the cholesterol-lowering drugs ... prevent heart disease. These new standards bring the association ... Heart Association, which also recommend giving low- or high-dose statins ... with diabetes. "We agree that the decision to start ...
(Date:12/24/2014)... For chic ladies, new fashionable outfits are necessary when ... Holiday Wish List, Angeldress.co.uk has chosen some of ... ladies’ holiday wardrobe by launching a promotion on its cheap ... discount of 80% off, like a cheap suit. , “All ... chic wedding dresses are among the hottest items in the ...
(Date:12/24/2014)... December 24, 2014 Dr. Svetlana Gomer, ... across the nation gathered with US Marines on November ... raise funds for the Toys for Tots Literacy Program. ... thousands of new books and audio books for the ... underprivileged children this Christmas. It represents another major strike ...
Breaking Medicine News(10 mins):Health News:Abuse in Childhood Tied to Migraines in Adulthood 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 3
... and MDS Pharma Services, Goodwill, , ... (TSX: MDS; NYSE: MDZ ), a leading provider of ... update for fiscal 2008 performance. , Based on preliminary ... the range of $1,210 million to $1,220 million and adjusted EBITDA ...
... Congress are determined to complete the job started around 1900 and ... They plan to move fast, seize momentum, and not let go. ... on the offense," said former South Dakota Senator Tom Daschle, presumptive ... , The bill might well be S. 1, and ...
... plc (NASDAQ:, ICLR )(ISIN:IE0005711209), a global ... biotechnology and medical device industries,today announced that ... new cardiac,echocardiography analysis software solution. The software, ... viewed, measured and interpreted,in clinical trials and ...
... spending hundreds of millions annually to prevent dry skin... much of the ... can be taken to heal and protect the skin. , ... Denver, ... of the year for scores of people across the country suffering from ...
... out of Wake Forest University School of Medicine and the ... popular class of oral diabetic drugs doubles the risk of ... findings appear online today on the Web site for the ... the January 6 issue. , "We knew going into this ...
... highlights from the December issue of Mayo Clinic Women,s HealthSource ... Mayo Clinic Women,s HealthSource attribution is ... subscription information as your editorial policies permit: Visit www.bookstore.mayoclinic.com ... , , Who,s ...
Cached Medicine News:Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4Health News:Blitzkrieg Declared On American Medicine 2Health News:Blitzkrieg Declared On American Medicine 3Health News:ICON Medical Imaging Launches New Cardiac Echocardiography Analysis Software 2Health News:Top Tips To Naturally Heal Dry Skin And Moisturize This Winter 2Health News:Top Tips To Naturally Heal Dry Skin And Moisturize This Winter 3Health News:Popular class of diabetes drugs doubles risk of fractures in women 2Health News:Popular class of diabetes drugs doubles risk of fractures in women 3Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 2Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 3Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 4Health News:December 2008 Mayo Clinic Women's HealthSource Highlights Happiness, Dementia and Smoking 5
... The SkanWasher 400 is ... microplate washer with built-in ... The individual pressure settings ... very gentle wash to ...
Lab-Reader...
Fully automatic NRTL and CE certified microplate reader....
... a compact and versatile multilabel ... design allows up to six ... counting, luminescence, absorbance, and fluorescence ... and fluorescence polarization all on ...
Medicine Products: